(NASDAQ: FTRE) Fortrea Holdings's forecast annual revenue growth rate of -1.03% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 79.5%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.92%.
Fortrea Holdings's revenue in 2025 is $2,733,500,000.On average, 4 Wall Street analysts forecast FTRE's revenue for 2025 to be $238,550,490,000, with the lowest FTRE revenue forecast at $236,655,000,000, and the highest FTRE revenue forecast at $239,935,050,000. On average, 5 Wall Street analysts forecast FTRE's revenue for 2026 to be $233,464,860,000, with the lowest FTRE revenue forecast at $227,473,200,000, and the highest FTRE revenue forecast at $238,500,000,000.
In 2027, FTRE is forecast to generate $241,654,950,000 in revenue, with the lowest revenue forecast at $237,362,400,000 and the highest revenue forecast at $245,493,450,000.